FDA Adverse Event Injury Summary report: N

INFUSE BONE GRAFT

MDR report key: 3920230 · Received July 8, 2014

Report

Report Number
1030489-2014-03132
Event Type
Injury
Date Received
July 8, 2014
Report Date
June 18, 2014
Manufacturer
MEDTRONIC SOFAMOR DANEK USA, INC
Product Code
NEK
PMA / PMN Number
P000058
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
KY, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

(B)(4). NEITHER THE DEVICE NOR FILMS OF APPLICABLE IMAGING STUDIES WERE RETURNED TO THE MANUFACTURER FOR EVALUATION. THEREFORE, WE ARE UNABLE TO DETERMINE THE DEFINITIVE CAUSE OF THE REPORTED EVENT. PRODUCTS FROM MULTIPLE MANUFACTURERS WERE IMPLANTED DURING THE PROCEDURE. ALTHOUGH IT IS UNKNOWN IF ANY OF THE DEVICES CONTRIBUTED TO THE REPORTED EVENT, WE ARE FILING THIS MDR FOR NOTIFICATION PURPOSES.

Description of Event or Problem · 1

IT WAS REPORTED THAT IN (B)(6) 2010, THE PATIENT WAS EXPERIENCING PROBLEMS USING HIS LEGS. ONE MONTH LATER, PATIENT CONSULTED THE SURGEON. IN (B)(6) 2010, PATIENT UNDERWENT A FUSION PROCEDURE AT L4-L5, L5-S1 USING RHBMP-2/ACS OR PUREGEN. FOLLOWING THE SURGERY, PATIENT BEGAN TO SUFFER FROM PAIN IN HIS MID BACK AND IN HIS RIBS. IN (B)(6) 2011, PATIENT UNDERWENT A SPINAL FUSION AT C5-C6 USING RHBMP-2/ACS OR PUREGEN. DURING THIS SURGERY, PATIENT'S DIAPHRAGM WAS TORN WHEN THE CHEST TUBE WAS TAKEN OUT. IN (B)(6) 2011, PATIENT UNDERWENT AN INSTRUMENTAL FUSION PROCEDURE AT T7-T10 USING RHBMP-2/ACS OR PUREGEN. FOLLOWING THESE SURGERIES, PATIENT BEGAN EXPERIENCING NEW PAIN IN HIS RIGHT SIDE, BACK PAIN AND ULTIMATELY COULD NO LONGER WORK. IN (B)(6) 2012, PATIENT UNDERWENT A FORAMINOTOMY AND HEMILAMINECTOMY FROM C5-C7 USING RHBMP-2/ACS OR PUREGEN. SINCE THESE SURGERIES, PATIENT HAS BEEN UNABLE TO WORK AND CANNOT WALK.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
397263 INFUSE BONE GRAFT FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET NEK MEDTRONIC SOFAMOR DANEK USA, INC NA UNK

Patients

Seq Age Sex Outcome Treatment
1 Other